Sign Up Now to Download a Free Research Report on PPHM

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts





Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals shares traded in the range of $1.76 to $2.06 Monday on volume of nearly 19 million shares traded. The company announced that it has reached an agreement with the FDA on a Phase III registration trial design for bavituximab in second-line non-small cell lung cancer (NSCLC).

Going forward ... (see research report)



RESEARCH REPORT ON PPHM Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on